Jianwei Lu

2.6k total citations
65 papers, 1.0k citations indexed

About

Jianwei Lu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jianwei Lu has authored 65 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 27 papers in Oncology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jianwei Lu's work include Gastric Cancer Management and Outcomes (14 papers), RNA modifications and cancer (11 papers) and Cancer-related molecular mechanisms research (9 papers). Jianwei Lu is often cited by papers focused on Gastric Cancer Management and Outcomes (14 papers), RNA modifications and cancer (11 papers) and Cancer-related molecular mechanisms research (9 papers). Jianwei Lu collaborates with scholars based in China, United States and South Korea. Jianwei Lu's co-authors include Jifeng Feng, Jian Wu, Yuejiao Zhong, Xiaohua Pan, Yajing Wang, Xiaohua Wang, Wei Peng, Min‐Bin Chen, You Shuai and Zhonghua Ma and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jianwei Lu

61 papers receiving 1.0k citations

Peers

Jianwei Lu
Xiaoyan Bai China
Annalisa Altimari Italy
Wenlei Zhuo China
Junfeng Zhang China
Zhao‐Ru Dong China
Chao Ma China
Dinghua Yang China
Xuelong Jiao China
Zhe Su China
Zuli Yang China
Xiaoyan Bai China
Jianwei Lu
Citations per year, relative to Jianwei Lu Jianwei Lu (= 1×) peers Xiaoyan Bai

Countries citing papers authored by Jianwei Lu

Since Specialization
Citations

This map shows the geographic impact of Jianwei Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianwei Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianwei Lu more than expected).

Fields of papers citing papers by Jianwei Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianwei Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianwei Lu. The network helps show where Jianwei Lu may publish in the future.

Co-authorship network of co-authors of Jianwei Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianwei Lu. A scholar is included among the top collaborators of Jianwei Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianwei Lu. Jianwei Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zheng, Yu, et al.. (2024). Zwitterionic derivatization of rhamnolipids: An efficient and biologically friendly antibacterial agent. Chemical Engineering Journal. 500. 156954–156954.
3.
Bao, Tingting, et al.. (2023). HKDC1 Silencing Inhibits Proliferation and Glycolysis of Gastric Cancer Cells. Journal of Oncology. 2023. 1–15. 7 indexed citations
4.
Pan, Banzhou, Jiayuan Huang, Bo Shen, et al.. (2023). CircRNA G6PC3 promotes lung adenocarcinoma progression through enhancing HMGB1/Beclin 1 complex to induce autophagy. Biomedical Signal Processing and Control. 90. 105758–105758. 1 indexed citations
5.
Huang, Xing, Shaorong Yu, Bo Shen, et al.. (2022). A Prognostic Risk Model of a Novel Oxidative Stress‐Related Signature Predicts Clinical Prognosis and Demonstrates Immune Relevancy in Lung Adenocarcinoma. Oxidative Medicine and Cellular Longevity. 2022(1). 2262014–2262014. 6 indexed citations
6.
7.
Zhong, Yongchun, et al.. (2020). Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer. SHILAP Revista de lepidopterología. 2 indexed citations
8.
Shen, Yan, et al.. (2020). The Combined Use of Chemotherapy and Radiotherapy with PD-1 Inhibitor, Pembrolizumab, in Advanced Cervical Cancer: A Case Report. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Li, Chenchen, Wei Zhao, Xuan Pan, et al.. (2020). LncRNA KTN1-AS1 promotes the progression of non-small cell lung cancer via sponging of miR-130a-5p and activation of PDPK1. Oncogene. 39(39). 6157–6171. 44 indexed citations
10.
Pan, Xiaoting, Yuanjie Liu, Pan Huang, et al.. (2020). A clinical study of traditional Chinese medicine prolonging the survival of advanced gastric cancer patients by regulating the immunosuppressive cell population. Medicine. 99(16). e19757–e19757. 28 indexed citations
11.
Wang, Yajing, et al.. (2020). <p>KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research</p>. OncoTargets and Therapy. Volume 13. 12601–12613. 19 indexed citations
12.
Peng, Wei, Yuejiao Zhong, Yan Sun, et al.. (2019). Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer. Scientific Reports. 9(1). 19084–19084. 28 indexed citations
13.
Wang, Xiaohua, Guifang Xu, Jingyuan Zhang, et al.. (2019). The clinical and prognostic significance of paraoxonase-2 in gastric cancer patients: immunohistochemical analysis. Human Cell. 32(4). 487–494. 15 indexed citations
14.
Wu, Zhen, Lixia Zhou, Wei Yin, et al.. (2018). Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant setting. SHILAP Revista de lepidopterología. 2 indexed citations
15.
Zhao, Ting, Hua Jiang, Jianwei Lu, et al.. (2017). [Prognostic significance of early assessment of minimal residual disease in acute myeloid leukemia with mutated NPM1 patients].. PubMed Central. 38(1). 10–16. 3 indexed citations
16.
Shi, Yong-Guo, Jianwei Lu, Jing Zhou, et al.. (2014). Long non-coding RNA Loc554202 regulates proliferation and migration in breast cancer cells. Biochemical and Biophysical Research Communications. 446(2). 448–453. 64 indexed citations
17.
18.
Ji, Minghua, Jinhai Tang, Jianhua Zhao, et al.. (2012). Polymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patients. Cancer Biology & Therapy. 13(5). 264–271. 36 indexed citations
19.
Lu, Jianwei. (2011). Study on the relationship between polymorphisms of nucleotide excision repair enzyme gene and sensitivity to chemotherapy in advanced gastric cancer. 1 indexed citations
20.
Lu, Jianwei. (2010). Relationship between polymorphisms of XRCC1 gene and sensitivity to chemotherapy in advanced gastric cancer. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoyan Bai Breakdown of academic impact, for papers by Annalisa Altimari Breakdown of academic impact, for papers by Wenlei Zhuo Breakdown of academic impact, for papers by Junfeng Zhang Breakdown of academic impact, for papers by Zhao‐Ru Dong Breakdown of academic impact, for papers by Chao Ma Breakdown of academic impact, for papers by Dinghua Yang Breakdown of academic impact, for papers by Xuelong Jiao Breakdown of academic impact, for papers by Zhe Su Breakdown of academic impact, for papers by Zuli Yang
Rankless by CCL
2026